BioMarin to Participate at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England | BMRN Stock News
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will present at the Jefferies Global Healthcare Conference on November 18, 2025, at 10:30 AM GMT in London. An audio webcast of the presentation will be available live, with an archived version accessible on the company's website afterward. BioMarin is a biotechnology company focused on developing treatments for rare genetic conditions, with a strong pipeline of therapies.
, /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will present at the Jefferies Global Healthcare Conference on Tuesday, November 18, 2025, at 10:30 AM GMT in London, England in London.
An audio webcast of the presentation will be available live. The webcast can be accessed at:https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.
About BioMarin
BioMarin is a global biotechnology company dedicated to translating the promise of genetic discovery into medicines that make a profound impact on the life of each patient. The San Rafael, California-based company, founded in 1997, has a proven track record of innovation with eight commercial therapies and a strong clinical and preclinical pipeline. Using a distinctive approach to drug discovery and development, BioMarin pursues treatments that offer new possibilities for patients and families around the world navigating rare or difficult-to-treat genetic conditions. To learn more, please visit www.biomarin.com.
| Contacts: | |
| Investors | Media |
| Traci McCarty | Marni Kottle |
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. |
| (415) 455-7558 | (650) 374-2803 |
SOURCE BioMarin Pharmaceutical Inc.
